Hiroaki Naota

551 total citations
12 papers, 283 citations indexed

About

Hiroaki Naota is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Hiroaki Naota has authored 12 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 4 papers in Surgery. Recurrent topics in Hiroaki Naota's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Hiroaki Naota is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Hiroaki Naota collaborates with scholars based in Japan, France and Australia. Hiroaki Naota's co-authors include Hiroshi Shiku, Yoshihiro Miyahara, Satoshi Okumura, Atsunori Hiasa, Shigehisa Kitano, Hiroaki Ikeda, Shinichi Kageyama, Junichi Mineno, Takuma Kato and Taizo Shiraishi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Journal of Immunological Methods.

In The Last Decade

Hiroaki Naota

12 papers receiving 279 citations

Peers

Countries citing papers authored by Hiroaki Naota

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Naota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Naota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Naota more than expected).

Fields of papers citing papers by Hiroaki Naota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Naota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Naota. The network helps show where Hiroaki Naota may publish in the future.

Co-authorship network of co-authors of Hiroaki Naota

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Naota. A scholar is included among the top collaborators of Hiroaki Naota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Naota. Hiroaki Naota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	The safety and efficacy of Ringer's solution loading with rectal diclofenac for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis: The RESOLUTION‐PEP study 2023 ·SHILAP Revista de lepidopterología ·(unknown), Reiko Yamada, Toji Murabayashi, Shinya Sugimoto, Hajime Imai, (unknown), (unknown), (unknown), Hiroki Tanaka, (unknown), Kenichiro Nishikawa, Hiroaki Naota, Isao Moritani, (unknown), (unknown), Kyosuke Tanaka, Hayato Nakagawa	1
2	Long-term Outcomes of Therapeutic Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis in Patients ≥90 Years Old: A Multicenter Retrospective Study 2021 ·Internal Medicine ·Shinya Sugimoto, (unknown), (unknown), Haruka Nakamura, (unknown), (unknown), Jun Oyamada, Akira Kamei, (unknown), Masatoshi Aoki, Hiroaki Naota	6
3	MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours 2020 ·BMC Cancer ·Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Naota, Katsumi Mukai, Naozumi Harada, Hiroaki Ikeda, Hiroshi Shiku	33
4	Isolated pancreatic metastasis from malignant melanoma: a case report and literature review 2019 ·Clinical Journal of Gastroenterology ·(unknown), Reiko Yamada, Maki Kaneko, Hiroaki Naota, (unknown), Masami Tabata, Kazuhiko Kobayashi, Kyosuke Tanaka	17
5	[A case of alpha-fetoprotein-producing fetal gut-like small intestinal cancer]. 2013 ·PubMed ·Yasuyuki Tamai, Kazuhiko Kobayashi, (unknown), (unknown), (unknown), (unknown), (unknown), Hiroaki Naota, Takenari Yamanaka, (unknown)	1
6	siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions 2011 ·Gene Therapy ·(unknown), Takuma Kato, Yoshihiro Miyahara, Hiroaki Naota, Junichi Mineno, Hiroaki Ikeda, Hiroshi Shiku	51
7	[A CR case of colorectal cancer given 39 courses of FOLFOX]. 2009 ·PubMed ·Kazuhiko Kobayashi, M. Kaneko, (unknown), (unknown), (unknown), (unknown), Naoko Imai, Hiroaki Naota, Kenji Taniguchi	1
8	USEFULNESS OF ENHANCED-MAGNIFICATION ENDOSCOPY FOR ENDOSCOPIC SUBMUCOSAL DISSECTION 2007 ·Acta gastro-enterologica belgica ·Kyosuke Tanaka, Shigenori Kadowaki, Yasuhiko Hamada, Ryo Kosaka, (unknown), Hiroaki Naota, Naoko Imai, Mikio Yamanaka, Taizo Shiraishi, Hideki Toyoda	1
9	Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells 2006 ·Journal of Immunological Methods ·Hiroaki Naota, Yoshihiro Miyahara, Satoshi Okumura, Kiyotaka Kuzushima, Yoshiki Akatsuka, Atsunori Hiasa, Shigehisa Kitano, Takashi Takahashi, Atsushi Yuta, Yuichi Majima, Hiroshi Shiku	13
10	HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan 2006 ·Clinical Cancer Research ·Shigehisa Kitano, Shinichi Kageyama, Yasuhiro Nagata, Yoshihiro Miyahara, Atsunori Hiasa, Hiroaki Naota, Satoshi Okumura, Hiroshi Imai, Taizo Shiraishi, Masahiro Masuya, Masakatsu Nishikawa, Junzo Sunamoto, Kazunari Akiyoshi, Takashi Kanematsu, Andrew M. Scott, Roger Murphy, Eric W. Hoffman, Lloyd J. Old, Hiroshi Shiku	103
11	Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE 2005 ·Clinical Cancer Research ·Yoshihiro Miyahara, Hiroaki Naota, Lijie Wang, Atsunori Hiasa, Megumi Goto, Masato Watanabe, Shigehisa Kitano, Satoshi Okumura, (unknown), Atsushi Yuta, Yuichi Majima, François A. Lemonnier, Thierry Boon, Hiroshi Shiku	46
12	Treatment of Radiation-Induced Hemorrhagic Duodenitis with Argon Plasma Coagulation 2004 ·Endoscopy ·Hidemi Toyoda, Edgar Jaramillo, (unknown), Tatsuya Saito, (unknown), Hiroaki Naota, Tomohiro Sase, Toshihisa Mizuno, Hiroshi Shiku, Issei Imoto, Y Adachi	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact